EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV

Emily A Miller, Kathleen A McGinnis, E Jennifer Edelman, Termeh Feinberg, Kirsha S Gordon, Robert D Kerns, Brandon D L Marshall, Julie A Patterson, MaryPeace McRae

AIDS and Behavior · 2024

DOI: 10.1007/s10461-024-04494-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIDS and Behavior, 2024. Verfasst von Emily A Miller und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA, USA. Hauptthemen laut MEDLINE: Buprenorphine, HIV Infections, Opioid-Related Disorders, Opiate Substitution Treatment. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NIDA NIH HHS, NIAAA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment of opioid use disorder (OUD) with buprenorphine improves outcomes and mortality among people with HIV (PWH). However, engagement is low and is influenced by comorbidities. We examined the impact of patterns of co-occurring pain, substance use disorders (SUDs), and mental health diagnoses on buprenorphine initiation and retention in PWH. The Veterans Aging Cohort Study contained 7,875 patients (2,702 PWH and 5,173 without HIV) with new OUD clinical encounters (2008–2017). Buprenorphine initiation and retention were derived from prescription data. We identified patterns of co-occurring diagnoses (via ICD codes) and assessed the effects of class membership on both outcomes using latent class analysis and regression analyses. The mean age of patients was 55, 98% were male, 58% Black, 8% Hispanic, and only 8% initiated buprenorphine within 12 months of OUD diagnosis. Four classes of co-occurring diagnoses were identified: “Few Co-occurring Diagnoses” (42.3%); “Multiple Pain Conditions” (21.3%); “Pain + SUD” (18.4%) and “Pain + SUD + Mental Health” (18.0%). Patients in the “Pain + SUD” class and “Pain + SUD + Mental Health” class were significantly less likely to initiate buprenorphine and had 59% and 45% lower odds, respectively, of initiating buprenorphine compared with patients in the “Few Co-occurring Diagnoses” class; this effect did not vary by HIV status. Buprenorphine retention was not significantly associated with HIV status or class membership. However, Black Veterans were less likely to initiate or be retained in buprenorphine treatment. Higher comorbidity burden was negatively associated with buprenorphine initiation but not with retention. More research is warranted to determine other factors that may influence treatment retention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BuprenorphineHIV InfectionsOpioid-Related DisordersOpiate Substitution TreatmentVeteransComorbidityHumansMaleFemaleMiddle AgedAdultUnited StatesPainAnalgesics, OpioidMental DisordersSubstance-Related DisordersMental HealthCohort Studies

Stichwörter der Autor:innen

BuprenorphineHIVMental healthOpioid use disorderPopulation analysisVeterans

Substanzen

BuprenorphineAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA, USA.
  • VA Connecticut Healthcare System, West Haven, CT, USA.
  • Section of General Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
  • Kelly Government Solutions, Silver Spring, MD, USA.
  • Department of Biostatistics, Yale University School of Public Health, New Haven, CT, USA.
  • Center for Medical Informatics, Yale University School of Medicine, New Haven, CT, USA.

Förderung

  • NCATS NIH HHS
  • NIDA NIH HHS
  • NIAAA NIH HHS
  • National Institute on Alcohol Abuse and Alcoholism
  • National Institute on Drug Abuse

Zitieren

APA

Miller, E. A., McGinnis, K. A., Edelman, E. J., Feinberg, T., Gordon, K. S., Kerns, R. D., Marshall, B. D. L., Patterson, J. A., & McRae, M. (2024). Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV. AIDS and Behavior. https://doi.org/10.1007/s10461-024-04494-w

Vancouver

Miller EA, McGinnis KA, Edelman EJ, Feinberg T, Gordon KS, Kerns RD, et al. Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV. AIDS and Behavior. 2024. doi:10.1007/s10461-024-04494-w

BibTeX
@article{Miller2024,
  author = {Miller, Emily A and McGinnis, Kathleen A and Edelman, E Jennifer and Feinberg, Termeh and Gordon, Kirsha S and Kerns, Robert D and Marshall, Brandon D L and Patterson, Julie A and McRae, MaryPeace},
  title = {Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV},
  journal = {AIDS and Behavior},
  year = {2024},
  doi = {10.1007/s10461-024-04494-w}
}
Kostenlos starten →